Moody's Investors Service assigned its "Aa3" rating to Stanford (Calif.) Health Care's proposed $462 million series 2017A and $500 million series 2018.
Concurrently, Moody's is affirming its "Aa3" rating on SHC's outstanding debt.
The assignment and affirmation are a result of several factors, including SHC's large size, leading market position, strong reputation and favorable service area. Moody's also acknowledged the health system's heightened leverage as a result of upcoming capital projects.
The outlook is stable, reflecting Moody's expectation that Stanford will execute its new hospital project within budget.